MycoBiomDB – Record Details (MyCo_2611)

Biomarker Record Details

Database ID: MyCo_2611
DB IDMyCo_2611
TitleEffect of patient immunodeficiencies on the diagnostic performance of serological assays to detect Aspergillus-specific antibodies in chronic pulmonary aspergillosis
Year2021
PMID33529993
Fungal Diseases involvedChronic pulmonary aspergillosis
Associated Medical ConditionNone
GenusAspergillus
Speciesspp.
OrganismAspergillus spp.
Ethical StatementNone
Site of InfectionNone
Opportunistic invasiveOpportunistic
Sample typeBody fluid
Sample sourceSerum
Host GroupHuman
Host Common nameHuman
Host Scientific nameHomo sapiens
Biomarker NameMBL
Biomarker Full NameMannose-binding lectin
Biomarker TypeDiagnostic
BiomoleculeProtein
Geographical LocationUK
CohortHere performed a retrospective review of secondary data obtained from 167 CPA patients identified at the National Aspergillosis Centre (NAC) (Manchester, UK).
Cohort No.167 Patients
Age Group32-87
P ValueNone
SensitivityNone
SpecificityNone
Positive Predictive ValueNone
MICNone
Fold ChangeNone
PathwayNone
Disease Introduction MechanismInvasive aspergillosis occurs primarily in patients with profound, but sometimes temporary, immunodeficiency, in contrast to chronic pulmonary aspergillosis (CPA) which occurs in people with no discernible immunodeficiency state. Over the last few years, several subtle immune defects have been found in some, but not all, CPA patients including mannose binding lectin deficiency, poor encapsulated bacterial vaccine responses, low circulating T- and natural killer cells, and interleukin-12 and gamma interferon defects.
TechniqueELISA
Analysis MethodELISA Based
ELISA kitsAspergillus fumigatus IgG ELISA (Bordier Affinity Products, Crissier, Switzerland)
Assay DataNone
Validation Techniques usedELISA
Up Regulation Down RegulationDecrease
Sequence DataNone
External LinkNone